Sheets Smith Wealth Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
BG
Sheets Smith Wealth Management's AGN Position: Q1 2018 in Review
Sheets Smith Wealth Management sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 17,905 shares — an estimated $2.93M sold.
Sheets Smith Wealth Management first reported a position in AGN in Q2 2013 and held it in 18 quarters. The position peaked at $9.07M in Q2 2015. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.
- Sheets Smith Wealth Management reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
- Sheets Smith Wealth Management sold 17,905 Allergan plc shares in Q1 2018, an estimated $2.93M.
- Sheets Smith Wealth Management first reported a position in Allergan plc in Q2 2013 and held it in 18 quarters.
- Sheets Smith Wealth Management's Allergan plc position peaked at $9.07M in Q2 2015.
- 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.
Based on Sheets Smith Wealth Management's 13F filing for Q1 2018, filed 9 Apr 2018.